Preferred Label : interleukin 1 receptor antagonist protein;

MeSH definition : A ligand that binds to but fails to activate the INTERLEUKIN 1 RECEPTOR. It plays an inhibitory role in the regulation of INFLAMMATION and FEVER. Several isoforms of the protein exist due to multiple ALTERNATIVE SPLICING of its mRNA.;

MeSH synonym : il1 inhibitor, urine-derived; il1 febrile inhibitor; urine-derived il1 inhibitor; urine derived il1 inhibitor; febrile inhibitor, il1; interleukin 1 inhibitor, urine; il-1 inhibitor, urine; il 1 inhibitor, urine; urine il-1 inhibitor; il-1ra;

CISMeF synonym : amgen brand of anakinra; anakinra amgen brand; anakinra synergen brand; synergen brand of anakinra;

MeSH hyponym : anakinra; antril; kineret;

MeSH Related Number : anakinra; 9013DUQ28K;

Related CAS MeSH : 9013DUQ28K (Anakinra);

Wikipedia link : https://en.wikipedia.org/wiki/Anakinra;

Is substance : O;

Details


Main resources

You can consult :

A ligand that binds to but fails to activate the INTERLEUKIN 1 RECEPTOR. It plays an inhibitory role in the regulation of INFLAMMATION and FEVER. Several isoforms of the protein exist due to multiple ALTERNATIVE SPLICING of its mRNA.

https://www.has-sante.fr/jcms/p_3329208/fr/kineret-anakinra-covid-19
2022
France
evaluation of the transparency committee
traction
Anakinra
kineret
indicators
interleukin 1 receptor antagonist protein
indication of
COVID-19
indicators and reagents
anakinra

---
https://www.cochrane.org/fr/CD015308/EMERG_les-medicaments-qui-bloquent-linterleukine-1-une-proteine-impliquee-dans-les-reponses-immunitaires
2022
false
false
false
United Kingdom
interleukin 1 receptor antagonist protein
interleukin 1 receptor antagonist protein
review of literature
french abstract
COVID-19

---
https://www.has-sante.fr/jcms/p_3221969/fr/kineret-fievre-mediterraneenne-familiale-fmf
2020
false
false
false
France
treatment outcome
insurance, health, reimbursement
anakinra
familial mediterranean fever
injections, subcutaneous
guidelines for drug use
evaluation of the transparency committee
anakinra
interleukin 1 receptor antagonist protein

---
https://www.inesss.qc.ca/covid-19/traitements-specifiques-a-la-covid-19/biotherapies-ciblant-la-voie-de-linterleukine-1.html
2020
false
false
false
Canada
pneumonia, viral
coronavirus infections
Interleukin-1
anakinra
canakinumab
guideline
biological therapy
interleukin 1 receptor antagonist protein
pandemics
pneumonia, viral
coronavirus infections
pandemics
antibodies, monoclonal
COVID-19

---
https://www.has-sante.fr/portail/jcms/c_2912136/fr/kineret
https://www.has-sante.fr/portail/jcms/c_2912136/fr/kineret-anakinra-immunosuppresseur
2019
false
true
false
false
France
injections, subcutaneous
treatment outcome
insurance, health, reimbursement
adult
adolescent
child
infant
Still's disease, Adult-Onset
arthritis, juvenile
antirheumatic agents
anakinra
interleukin 1 receptor antagonist protein
interleukin 1 receptor antagonist protein
guidelines for drug use
evaluation of the transparency committee
anakinra
interleukin 1 receptor antagonist protein

---
https://www.ansm.sante.fr/actualites/modification-des-conditions-de-prescription-et-delivrance-de-certaines-biotherapies-utilisees-dans-le-traitement-de-maladies-inflammatoires-chroniques-en-rhumatologie-gastroenterologie-dermatologie-ophtalmologie
2019
false
false
false
France
French
drug prescriptions
drug information
Adalimumab
Etanercept
golimumab
Certolizumab Pegol
anakinra
interleukin 1 receptor antagonist protein
antibodies, monoclonal

---
http://www.has-sante.fr/portail/jcms/c_1765197/fr/kineret
2014
false
France
French
adolescent
child
infant
cryopyrin-associated periodic syndromes
chronic infantile neurological, cutaneous, and articular syndrome
familial cold autoinflammatory syndrome
Muckle-Wells syndrome
treatment outcome
guidelines for drug use
insurance, health, reimbursement
drug therapy, combination
arthritis, rheumatoid
antirheumatic agents
injections, subcutaneous
interleukin 1 receptor antagonist protein
anakinra
evaluation of the transparency committee
anakinra
adult
methotrexate

---
http://www.has-sante.fr/portail/jcms/c_1749748/fr/kineret
http://www.has-sante.fr/portail/jcms/c_1701280/fr/kineret
http://www.has-sante.fr/portail/display.jsp?id=c_399561
http://www.has-sante.fr/portail/display.jsp?id=c_642557
2014
false
France
French
insurance, health, reimbursement
drug therapy, combination
arthritis, rheumatoid
antirheumatic agents
injections, subcutaneous
interleukin 1 receptor antagonist protein
anakinra
evaluation of the transparency committee
anakinra
adult
methotrexate

---
http://www.cri-net.com/fiches-pratiques-et-recommandations/prise-en-charge-pratique-des-patients-sous-anti-il1
2013
false
true
false
France
French
interleukin 1 receptor antagonist protein
interleukin 1 receptor antagonist protein
patient care management
continuity of patient care
guidelines for drug use
practice guideline
patients guideline
consensus
adolescent
child
adult
arthritis, rheumatoid
anakinra
anakinra
canakinumab
canakinumab
anakinra
canakinumab
Interleukin-1beta
cryopyrin-associated periodic syndromes
Juvenile-Onset still disease
Still's disease, Adult-Onset
rheumatoid arthritis, systemic juvenile
Idiopathic recurrent pericarditis
pericarditis
Castleman Disease
schnitzler syndrome
familial mediterranean fever
Erdheim-Chester disease
rare diseases
mevalonate kinase deficiency
periodic fever, familial, autosomal dominant
rilonacept
rilonacept
rilonacept
injections, subcutaneous
arthritis, juvenile
antibodies, monoclonal
antibodies, monoclonal
fever
hereditary autoinflammatory diseases
recombinant fusion proteins
recombinant fusion proteins

---
https://www.ema.europa.eu/medicines/human/EPAR/Kineret
2011
false
United Kingdom
French
English
syndication feed
arthritis, rheumatoid
interleukin 1 receptor antagonist protein
treatment outcome
immunosuppressive agents
drug therapy, combination
Interleukin-1
anakinra
drug evaluation
summary of product characteristics
package leaflet

---
http://www.cochrane.org/fr/CD005121
2009
false
true
false
United Kingdom
France
interleukin 1 receptor antagonist protein
treatment outcome
review of literature
french abstract
arthritis, rheumatoid

---
https://www.cadth.ca/sites/default/files/pdf/149_anakinra_cetap_f.pdf
https://www.cadth.ca/sites/default/files/pdf/149_anakinra_cetap_e.pdf
2001
Canada
French
English
interleukin 1 receptor antagonist protein
canada
antirheumatic agents
arthritis, rheumatoid
treatment outcome
Evidence-Based medicine
injections, subcutaneous
clinical trials as topic
interleukin 1 receptor antagonist protein
antirheumatic agents
united states
anakinra
drug evaluation

---
Nous contacter.
16/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.